Literature DB >> 9680371

The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells.

L M Larocca1, D Capello, A Rinelli, S Nori, A Antinori, A Gloghini, A Cingolani, A Migliazza, G Saglio, S Cammilleri-Broet, M Raphael, A Carbone, G Gaidano.   

Abstract

Primary central nervous system lymphoma (PCNSL) is a major cause of morbidity and mortality among human immunodeficiency virus (HIV)-infected individuals. The precise histogenetic derivation and the molecular pathogenesis of PCNSL is poorly understood. In an attempt to clarify the histogenesis and pathogenesis of these lymphomas, 49 PCNSL (26 acquired immunodeficiency syndrome [AIDS]-related and 23 AIDS-unrelated) were analyzed for multiple biologic markers, which are known to bear histogenetic and pathogenetic significance for mature B-cell neoplasms. PCNSL associated frequently (50.0%) with mutations of BCL-6 5' noncoding regions, which are regarded as a marker of B-cell transition through the germinal center (GC). Expression of BCL-6 protein, which is restricted to GC B cells throughout physiologic B-cell maturation, was detected in 100% AIDS-unrelated PCNSL and in 56.2% AIDS-related cases. Notably, among AIDS-related PCNSL, expression of BCL-6 was mutually exclusive with expression of Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP)-1 and, with few exceptions, also of BCL-2. All but one PCNSL expressed hMSH2, which among mature B cells selectively stains GC B cells. These data suggest that PCNSL may be frequently related to GC B cells and may be segregated into two major biologic categories based on the expression pattern of BCL-6, LMP-1, and BCL-2. BCL-6(+)/LMP-1(-)/BCL-2(-) PCNSL occur both in the presence and in the absence of HIV infection and consistently display a large noncleaved cell morphology. Conversely, BCL-6(-)/LMP-1(+)/BCL-2(+) PCNSL are restricted to HIV-infected hosts and are represented by lymphomas with immunoblastic features. These data are relevant for the pathogenesis and histogenesis of PCNSL and may be helpful to segregate distinct biologic and prognostic categories of these lymphomas. Copyright 1998 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9680371

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

Review 1.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

2.  Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study.

Authors:  Hui-Lee Wong; Elizabeth C Breen; Ruth M Pfeiffer; Brahim Aissani; Jeremy J Martinson; Joseph B Margolick; Richard A Kaslow; Lisa P Jacobson; Richard F Ambinder; Stephen Chanock; Otoniel Martínez-Maza; Charles S Rabkin
Journal:  AIDS       Date:  2010-04-24       Impact factor: 4.177

3.  Chromosomal imbalances in primary lymphomas of the central nervous system.

Authors:  C H Rickert; B Dockhorn-Dworniczak; R Simon; W Paulus
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment.

Authors:  M Montesinos-Rongen; R Küppers; D Schlüter; T Spieker; D Van Roost; C Schaller; G Reifenberger; O D Wiestler; M Deckert-Schlüter
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

5.  Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; H Irene Hall; Jianmin Li; James J Goedert; Lindsay M Morton; Patricia Hartge; Eric A Engels
Journal:  JAMA       Date:  2011-04-13       Impact factor: 56.272

6.  Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients.

Authors:  Wilhelm Küker; Thomas Nägele; Agnieska Korfel; Stefan Heckl; Eckhard Thiel; Michael Bamberg; Michael Weller; Ulrich Herrlinger
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

7.  Phenotypic change of human cultured meningioma cells.

Authors:  R Pallini; P Casalbore; D Mercanti; N Maggiano; L M Larocca
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

8.  Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell.

Authors:  M Montesinos-Rongen; A Brunn; S Bentink; K Basso; W K Lim; W Klapper; C Schaller; G Reifenberger; J Rubenstein; O D Wiestler; R Spang; R Dalla-Favera; R Siebert; M Deckert
Journal:  Leukemia       Date:  2007-11-08       Impact factor: 11.528

9.  Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1.

Authors:  Annunziata Gloghini; Gianluca Gaidano; Luigi M Larocca; Francesco Pierconti; Antonella Cingolani; Luigino Dal Maso; Daniela Capello; Silvia Franceschi; Umberto Tirelli; Massimo Libra; Huifeng Niu; Riccardo Dalla-Favera; Antonino Carbone
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

Review 10.  Insights into the biology of primary central nervous system lymphoma.

Authors:  Maciej M Mrugala; James L Rubenstein; Maurilio Ponzoni; Tracy T Batchelor
Journal:  Curr Oncol Rep       Date:  2009-01       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.